An Official Website of the United States Government
Company Information:
Name:
POTENTIA PHARMACEUTICALS, INC
Address:
POTENTIA PHARMACEUTICALS, INC
201 E JEFFERSON ST, STE 312
LOUISVILLE, KY 40202
201 E JEFFERSON ST, STE 312
LOUISVILLE, KY 40202
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Bypassing fluidics in proteomic screening
Award Year / Program / Phase:
2004 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Pascal Deschatelets
Award Amount:
$504,000.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is to develop a new, groundbreaking technology for the rapid identification of ligands for proteins. Every year, the pharmaceuticals industry loses about $3 billion by targeting genes/proteins wrongfully identified as the cause of… More
Modified bacterial system for vivo direction evolution
Award Year / Program / Phase:
2004 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Paul K. Olson
Award Amount:
$252,798.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is to develop a new genetic system that will mimic the natural process of evolution for a selected subset of genes inside of a bacterial cell. Instead of an evolutionary time scale of years, evolution will proceed at an accelerated rate… More
Targeting drug delivery nanoparticles to sites of inflammation
Award Year / Program / Phase:
2008 / STTR / Phase II
Agency:
HHS
Research Institution:
N/A
Principal Investigator:
Award Amount:
$977,329.00
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The purpose of this Phase II STTR project is to develop a nanoparticle-based drug delivery system for use in the treatment of dry age-related macular degeneration (AMD). AMD is the leading cause of blindness for individ
uals over fifty-five years of age that live… More